Johnson & Johnson (JNJ)
Total asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 88,607,000 | 84,021,000 | 79,428,000 | 93,356,000 | 82,174,000 |
Total assets | US$ in thousands | 180,104,000 | 167,558,000 | 187,378,000 | 182,018,000 | 174,894,000 |
Total asset turnover | 0.49 | 0.50 | 0.42 | 0.51 | 0.47 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $88,607,000K ÷ $180,104,000K
= 0.49
Johnson & Johnson's total asset turnover ratio has shown fluctuations over the past five years. The ratio was 0.47 in 2020, increased to 0.51 in 2021, decreased to 0.42 in 2022, then improved to 0.50 in 2023, and remained relatively stable at 0.49 in 2024. This indicates that, on average, for each dollar of total assets, the company generated sales of $0.47 in 2020, $0.51 in 2021, $0.42 in 2022, $0.50 in 2023, and $0.49 in 2024. Overall, the company's ability to generate revenue from its assets has slightly improved from 2020 to 2024, with some fluctuations in between.
Peer comparison
Dec 31, 2024
Company name
Symbol
Total asset turnover
Johnson & Johnson
JNJ
0.49
Abbott Laboratories
ABT
0.54
AbbVie Inc
ABBV
0.40
Alkermes Plc
ALKS
0.76
Amphastar P
AMPH
0.46
ANI Pharmaceuticals Inc
ANIP
0.50
Arcus Biosciences Inc
RCUS
0.22
Biomarin Pharmaceutical Inc
BMRN
0.41
Bristol-Myers Squibb Company
BMY
0.52
Catalent Inc
CTLT
0.45
Catalyst Pharmaceuticals Inc
CPRX
0.85